CA2839606A1 - Indene derivatives for use in the treatment of inflammatory bowel disease - Google Patents
Indene derivatives for use in the treatment of inflammatory bowel disease Download PDFInfo
- Publication number
- CA2839606A1 CA2839606A1 CA2839606A CA2839606A CA2839606A1 CA 2839606 A1 CA2839606 A1 CA 2839606A1 CA 2839606 A CA2839606 A CA 2839606A CA 2839606 A CA2839606 A CA 2839606A CA 2839606 A1 CA2839606 A1 CA 2839606A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- tert
- mice
- compounds
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- RQEUFEKYXDPUSK-UHFFFAOYSA-O CC(c1ccccc1)[NH3+] Chemical compound CC(c1ccccc1)[NH3+] RQEUFEKYXDPUSK-UHFFFAOYSA-O 0.000 description 1
- COXZEKKBJOWBAG-RSXGOPAZSA-N O[C@@H]1c2ccccc2C[C@@]1(Cc(cc1)ccc1C(O)=O)C1=Cc2ccccc2C1 Chemical compound O[C@@H]1c2ccccc2C[C@@]1(Cc(cc1)ccc1C(O)=O)C1=Cc2ccccc2C1 COXZEKKBJOWBAG-RSXGOPAZSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/19—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups having unsaturation outside the aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
- C07C65/17—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161510628P | 2011-07-22 | 2011-07-22 | |
| US61/510,628 | 2011-07-22 | ||
| PCT/IE2012/000037 WO2013014659A1 (en) | 2011-07-22 | 2012-07-20 | Indene derivatives for use in the treatment of inflammatory bowel disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2839606A1 true CA2839606A1 (en) | 2013-01-31 |
Family
ID=46584089
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2839606A Abandoned CA2839606A1 (en) | 2011-07-22 | 2012-07-20 | Indene derivatives for use in the treatment of inflammatory bowel disease |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9586885B2 (enExample) |
| EP (1) | EP2734496A1 (enExample) |
| JP (1) | JP5898768B2 (enExample) |
| CN (1) | CN103764608B (enExample) |
| AU (1) | AU2012288404A1 (enExample) |
| BR (1) | BR112014001551A2 (enExample) |
| CA (1) | CA2839606A1 (enExample) |
| NZ (1) | NZ618936A (enExample) |
| RU (1) | RU2601307C2 (enExample) |
| TW (1) | TWI537246B (enExample) |
| WO (1) | WO2013014659A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013014660A1 (en) * | 2011-07-22 | 2013-01-31 | Venantius Limited | Indane dimers for use in the treatment of autoimmune inflammatory disease |
| CN110426464B (zh) * | 2019-07-08 | 2022-03-04 | 苏州正济药业有限公司 | 一种葡甲胺中异构体的hplc检测方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2322859A (en) * | 1995-12-06 | 1998-09-09 | Venantius Limited | Indane compounds with smooth muscle relaxing and/or mast cell stabilising and/or anti-inflammatory activity |
| DE19619036A1 (de) | 1996-04-30 | 1997-11-13 | Schering Ag | Neue Vitamin D-Derivate mit carbo- oder heterocyclischen Substituenten an C-25, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln |
| AU3899097A (en) * | 1996-08-05 | 1998-02-25 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Substituted aromatic compounds |
| EP1032385A1 (en) * | 1997-11-20 | 2000-09-06 | Children's Medical Center Corporation | Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cellproliferation, diarrhe and scours |
| US20020128256A1 (en) * | 1997-11-20 | 2002-09-12 | Carlo Brugnara | Methods for the treatment or prevention of inflammatory diseases characterized by abnormal cell proliferation |
| ES2240201T3 (es) * | 1999-10-20 | 2005-10-16 | Tanabe Seiyaku Co., Ltd. | Inhibidores de la adhesion molecular mediada por la alfa-l beta-2. |
| DE602004031410D1 (de) | 2003-04-15 | 2011-03-31 | Aquinox Pharmaceuticals Inc | Inden derivate als pharmazeutika |
| US7592461B2 (en) * | 2005-12-21 | 2009-09-22 | Bristol-Myers Squibb Company | Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| WO2013014660A1 (en) | 2011-07-22 | 2013-01-31 | Venantius Limited | Indane dimers for use in the treatment of autoimmune inflammatory disease |
| EP2864279B1 (en) | 2012-05-24 | 2016-11-02 | Venantius Limited | Compounds for use in the treatment of autoimmune inflammatory disease |
| EP2855416A1 (en) | 2012-05-24 | 2015-04-08 | Venantius Limited | Indane dimers for use in the treatment of autoimmune inflammatory disease |
-
2012
- 2012-07-20 TW TW101126409A patent/TWI537246B/zh not_active IP Right Cessation
- 2012-07-20 WO PCT/IE2012/000037 patent/WO2013014659A1/en not_active Ceased
- 2012-07-20 CN CN201280035083.7A patent/CN103764608B/zh not_active Expired - Fee Related
- 2012-07-20 AU AU2012288404A patent/AU2012288404A1/en not_active Abandoned
- 2012-07-20 JP JP2014520787A patent/JP5898768B2/ja not_active Expired - Fee Related
- 2012-07-20 EP EP12740702.1A patent/EP2734496A1/en not_active Withdrawn
- 2012-07-20 RU RU2013155270/04A patent/RU2601307C2/ru not_active IP Right Cessation
- 2012-07-20 CA CA2839606A patent/CA2839606A1/en not_active Abandoned
- 2012-07-20 US US14/124,937 patent/US9586885B2/en not_active Expired - Fee Related
- 2012-07-20 BR BR112014001551-1A patent/BR112014001551A2/en not_active IP Right Cessation
- 2012-07-20 NZ NZ618936A patent/NZ618936A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2013155270A (ru) | 2015-08-27 |
| US9586885B2 (en) | 2017-03-07 |
| WO2013014659A1 (en) | 2013-01-31 |
| TW201311637A (zh) | 2013-03-16 |
| CN103764608B (zh) | 2016-02-03 |
| CN103764608A (zh) | 2014-04-30 |
| JP5898768B2 (ja) | 2016-04-06 |
| HK1196597A1 (zh) | 2014-12-19 |
| EP2734496A1 (en) | 2014-05-28 |
| JP2014524921A (ja) | 2014-09-25 |
| US20140128466A1 (en) | 2014-05-08 |
| NZ618936A (en) | 2015-07-31 |
| TWI537246B (zh) | 2016-06-11 |
| AU2012288404A1 (en) | 2014-01-09 |
| BR112014001551A2 (en) | 2017-06-13 |
| RU2601307C2 (ru) | 2016-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7519102B2 (ja) | カンナビノイドの共結晶の固体組成物 | |
| JP2005535712A (ja) | レソルビン：治療処置用のバイオテンプレート | |
| CA2615077A1 (en) | Use of 3,1ib-cis-dihydrotetrabenazine for the treatment of symptoms of huntington's disease | |
| JP2019523245A (ja) | オーファン核内受容体Ｎｕｒ７７のリガンド及びその使用 | |
| US5786380A (en) | VPA-analogous antiepileptics | |
| US9586885B2 (en) | Compounds for use in the treatment of inflammatory bowel disease | |
| US7019034B2 (en) | Compositions and methods for reducing serum glucose and triglyceride levels in diabetic mammals | |
| JPH05502243A (ja) | ３―置換及び３，３―ジ置換４―オキソレチノイン酸及びそれらのエステル | |
| EP2734497A1 (en) | Indane dimers for use in the treatment of autoimmune inflammatory disease | |
| US9260376B2 (en) | Compounds for use in the treatment of immune related inflammatory disease | |
| JP5399249B2 (ja) | ３環系アミン化合物 | |
| EP2855416A1 (en) | Indane dimers for use in the treatment of autoimmune inflammatory disease | |
| WO2010041253A1 (en) | Compositions comprising cb receptor agonists, uses thereof and methods for their preparation | |
| JP4345311B2 (ja) | 抗酸化剤 | |
| HK1196597B (en) | Indene derivatives for use in the treatment of inflammatory bowel disease | |
| CN103260614B (zh) | 联合疗法 | |
| US10799496B2 (en) | Naphthylenyl compounds for long-acting injectable compositions and related methods | |
| AU761572B2 (en) | 5,6-dihydronaphthalenyl derivatives having retinoid-like activity | |
| EP4594332A1 (en) | Modulators of cd1 protein binding to t cell receptors | |
| WO2020094634A1 (en) | Thiophene prodrugs of naltroxene for long-acting injectable compositions and related methods | |
| RU2173683C2 (ru) | Ретиноиды и фармацевтическая композиция, их содержащая | |
| CN111727039A (zh) | 大肠炎改善剂 | |
| JPH1072345A (ja) | ９−シス−レチノイン酸−α−トコフェロールエステルを含有する白血病治療剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20180720 |